Dynavax Technologies



Ebit Veränderung Datum
AbbVie USD 5.24B 1.5B 2024-12
Adma Biologics USD 37.59M 2.05M 2024-12
Amgen USD 4.03B 11M 2024-12
AstraZeneca USD 4.2B 119M 2024-12
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Dynavax Technologies USD -1632000 11.71M 2024-12
Gilead Sciences USD 2.89B 221M 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Merck USD 5.22B 339M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Dynavax Technologies - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.